Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32438 total
Energy Fuels has had a remarkable week — a 14% rally following a strong Q2 print, record uranium production headlines, and a short base that is quietly rebuilding even as bulls celebrate. The most important shift since…
UDR enters the week with a notable split: the stock is under pressure from a Morgan Stanley target cut, yet the short sellers who drove months of skepticism are exiting at an unusually rapid pace. The most striking…
Melco Resorts & Entertainment heads into its August 13 earnings release with options positioning quietly shifting more defensive — even as short sellers continue to retreat. The sharpest signal this week comes from the…
CSIQ walks into its August 14 results with a peculiar setup: short sellers are cutting exposure at the fastest pace in months, yet the short score remains near the top of the universe and the stock still carries one of…
NNN REIT enters the week of August 12 caught in a familiar bind: analysts are quietly raising their price targets after the Q2 print, yet none are willing to move off the sidelines — and the stock has kept falling…
USO has just delivered its best week in months — up 10.2% to $127.61 — and the shorts that piled in during the sell-off are now nursing real pain, with the borrow market flipping from tight to loose almost…
Energy Transfer LP has reversed its post-earnings dip with conviction — up 2.2% on the week and 5.7% over the past month to $20.78 — while the Street has responded to the Q2 print with a coordinated wave of target…
Under Armour has fallen 22% in a single week to $5.34, yet short sellers are covering aggressively — the two signals are pulling in opposite directions, and the next earnings print on August 26 sits squarely in the…
Expedia Group has delivered a textbook post-earnings re-rate — stock up nearly 19% over the past month, analyst targets chasing the move higher, and shorts quietly rebuilding after the pre-results covering rush…
NOVN heads into the back half of August in a quietly unusual position: the stock is up on the week while most of its closest peers are not, short sellers have almost no presence, and the analyst community sees…
SK hynix Inc. heads into mid-August at KRW 1,425,000 — down nearly 10% on the week and 35% over the past month — yet the borrow market is signalling almost no organised conviction behind the slide. The clearest feature…
2330 closes the week at TWD 2,395 — up 3.2% — partly reclaiming the territory lost in the post-earnings slide and putting the one-month decline to roughly 0.8%, a sharp improvement from the -5.1% that defined last…
Nokia Oyj heads into the back half of 2026 with a fresh cluster of insider buying on one side and a painful earnings-driven collapse on the other — a tension that makes the current setup genuinely interesting. The…
Wheaton Precious Metals has extended its post-earnings rally into a second week, with the stock up 15% on the week to CAD 186.98 — and the Q2 result that triggered the move has now been confirmed as a genuine positive…
Elevance Health heads into mid-August with an unusual dynamic: insiders buying aggressively into a stock that just took its biggest single-day earnings hit in recent memory, while short sellers use the recovery to trim…
Equity LifeStyle Properties enters the back half of August with the Street turning incrementally more cautious — just as short sellers quietly rebuild positions off recent lows. The freshest signal comes from the…
GOOGL has surrendered a chunk of its post-earnings recovery, dropping 9% in a week to close at $343.80 — erasing more than half of the rebound from the July 23 low of $317.69 to the recent peak near $378. The price…
CRM enters its August 26 earnings report carrying a striking divergence: short sellers have been covering aggressively while the Street remains split on whether Agentforce is a growth story or a distraction. The most…
MFIC heads into the back half of August with an unusual split: short sellers are unwinding at pace while the analyst community is busy lowering the bar. The short-covering story is the clearest trend in the data right…
Halozyme Therapeutics is in an unusual spot three days after its 23% earnings pop — the stock has stalled at $102.62 while shorts, far from covering, have barely moved. Short interest is marginally lower than it was…
